The Hunt For Gardasil Adverse Events: A Preview Of Emerging Social Media Challenges
This article was originally published in The Pink Sheet Daily
Executive Summary
Bachmann-based brouhaha over Merck's human papilloma virus vaccine underscores the liability risks that firms can face as possible risks for their products are discussed more widely.
You may also be interested in...
Merck’s Gardasil Adds Serotypes; Boosting Vaccinations Seems Bigger Challenge
Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.
Gardasil Getting Pediatric Safety Review
Despite the political noise around the human papillomavirus vaccine, there do not seem to be major new pediatric safety concerns for the Pediatric Advisory Committee to discuss as it reviews Gardasil and 14 other products.
Firms Navigate Social Media Safely Following Loss Of Facebook Protection
The drug industry has options beyond disappearing from Facebook and missing the opportunities the influential networking site offers.